Advances in therapy have yet to substantially improve the 5-year survival metrics for non-small cell lung cancer (NSCLC) patients, underscoring a significant gap that necessitates novel and efficacious treatment solutions. In this study, we demonstrated that t... ...

请注册登录后继续浏览